18 signals · bluesky, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Signal data from 1 source places Relay Therapeutics in the AI Drug Discovery / Biotech space at moderate workforce stress signals with low overall risk indicators.
Signals for Relay Therapeutics were collected from 1 source. Aggregate signal sentiment appears broadly positive. The stress score stands at 38/100 with a risk score of 6/100. These findings are based on a limited number of signals and may not be fully representative.
What this means
(RLAY) by 60.6% in the second quarter, now owning 801,464 shares valued at approximately $15 million.
Relay Therapeutics (NASDAQ:RLAY) Sets New 52-Week High Following Analyst Upgrade MarketBeat
EcoR1 Capital LLC Acquires Shares of 1,904,762 Relay Therapeutics, Inc.
AI-driven structure-based drug discovery.
Based on 18 signals across 2 sources · snapshot 27 Sept 2026
Moderate: directional, may shift as more signals arrive.
Overall community sentiment for Relay Therapeutics is positive based on public signals as of 27 Sept 2026.
Based on 18 signals across 2 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Signals suggest a mixed picture — review the evidence below for context.
AI-generated from public signals — may be incomplete. Based on 3 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.